|Physicians (Surgical Oncologists, Medical Oncologists, Radiation Oncologists, Gynaecologists, Pathologists, Imaging specialists, Geneticists, GPs)||250 EUR|
|Industry (Policy makers, regulatory, medical affairs)||250 EUR|
|Care Givers (Clinical, Community, Hospital & Oncology Pharmacists, nurses, palliative care specialists, rehabilitation specialists, psychologists)||150 EUR|
|Researchers (Epidemiologists, Scientists, Data Managers, Biostatisticians)||150 EUR|
|Emerging Economies****||75 EUR|
|Patient Advocates**||75 EUR|
|Students and Residents in Training***||75 EUR|
* Prices incl. 21% VAT.
** The patient advocate rate applies exclusively for individuals who are a member of Patient Advocate Organisation.
*** A letter from the Head of the Department is requested as a proof of the student status / resident in training
****World Bank Rate: Applies to individuals from low and lower-middle-income economies according to the World Bank listing
PLEASE NOTE: Access to the exhibition is restricted to prescribers only. Researchers, Patient Advocates or Student categories will not be able to gain access to the online virtual exhibition.
Methods of payment
All payments are in Euro (€) and the full amount must be received before access to the conference is given.
Accepted credit cards are: Mastercard or Visa.
To facilitate easy processing, please indicate your registration number in your remittance(s).
Confirmation of Registration
We will send you a final confirmation of your registration by email once your payment has been received.
Cancellation & refund
All cancellations are subject to a 50 EUR administration fee per participant. The deadline to receive the cancellation request is 15 September 2020.
Cancellation requests after this date are not refunded.
Terms and Conditions
To download the Terms and Conditions click here.
Accreditation for Italian Participants – Prerichiesta AIFA
Barbara Mantegazza has been appointed to manage all the legal documents required by Italian Legislative Order n.541 of December 30, 1992, art 12, Para 3.